Endothelial microparticle (EMP)

Endothelial microparticles (EMPs) are submicron extracellular vesicles, typically ranging from 100 nm to 1 μm in diameter, that are shed from the plasma membrane of endothelial cells in response to activation, injury, or apoptosis. They represent a specialized subset of endothelial-derived factors that act as mobile biological effectors, carrying a complex cargo of proteins, lipids, and genetic material, such as microRNAs, to target cells. In healthy physiological states, they participate in vascular homeostasis and cell-to-cell communication; however, their levels are significantly elevated in conditions characterized by endothelial dysfunction, including cardiovascular disease, diabetes mellitus, and systemic inflammation. EMPs are increasingly recognized as both diagnostic biomarkers for disease progression and potential therapeutic targets, with research focusing on pharmacological interventions that can reduce their shedding or block their pro-inflammatory and pro-thrombotic effects on the vasculature.

Other names

Endothelial-derived microparticleEndothelial-derived microvesicleEndothelial extracellular vesicleEndothelial-derived factorEndothelial-derived microparticle (EMP)

Reduction of endothelial cell activation and apoptosis to decrease the shedding of microparticles; inhibition of microparticle-mediated pro-inflammatory and pro-coagulant signaling pathways.